Skip to main content
. 2011 Feb 23;117(21):e198–e206. doi: 10.1182/blood-2010-06-292433

Table 5.

UPD lesions detected by SNP-A and affected candidate genes (N = 26)

Patient no. Disease Chromosome Start Stop Length, Mb Affected candidate genes
22 AP 5q22.1q33.3 110815528 157807809 46.99 APC, IRF1, TCF7, SKP1, CDKL3, PHF15, TIFAB, GFRA3, JMJD1B, ETF1, NRG2, HBEGF, ANKHD1, SRA1, HDAC3, NDFIP1, SPRY4, FGF1, ARHGAP26, NR3C1, TCERG1, PPP2R2B, PPARGC1B, CSF1R, PDGFRB, CDX1, RPS14, IRGM, ANXA6, FAT2, SPARC, ATOX1, G3BP1, HAND1, MRPL22, MED7, SOX30, CLINT1
22 AP 8q21.2q24.3 87129788 146263890 59.13 WWP1, RIPK2, MTG8, GEM, RAD54B, GDF6, RPL30, STK3, YWHAZ, GRHL2, RRM2B, UBR5, BAALC, FZD6, ZFPM2, EIF3E, EBAG9, CSMD3, TRPS1, EIF3H, MED30, SAMD12, TNFRSF11B, NOV, ENPP2, TAF2, DSCC1, ZHX1/2, ANXA13, MYC, WISP1, Cap43, NDRG1, ST3GAL1, CHRAC1, PTK2, PTP4A3, BAI1, JRK, MAFA, MAPK15, PUF60, FBXL6, NFKBIL2, RECQL4
44 Myeloid BP 11p15.5p12 194228 41346378 41.15 DUSP8, RASSF7, H19, IGF2, ASCL2, TSSC4, CDKN1C, NAP1L4, NUP98, RRM1, ILK, TPP1, NLRP10, STK33, ST5, WEE1, SBF2, AMPD3, MRVI1, EIF4G2, DKK3, TEAD1, ARNTL, RRAS2, SOX6, PTPN5, BBOX1, LGR4, METT5D1, ELP4, PAX6, WT1, HIPK3, COMMD9, TRAF6
44 Myeloid BP 17q11.2q25.3 27492835 78640854 51.15 Whole 17q

AP indicates accelerated phase; and BP, blast phase.